- Home
- / RBC Life Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
RBC Life Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$126.1 K
2024-10-29
Revenue
$28.3 M
FY, 2014
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 |
|---|---|---|---|
| Revenue | 25.2M | 25.5M | 28.3M |
| Cost of goods sold | 12.5M | 13.5M | 12.6M |
| Gross profit | 12.6M | 12.0M | 15.6M |
| Gross profit margin, % | 50.2% | 47.2% | 55.3% |
| General and administrative expense | 9.8M | 9.3M | 11.1M |
| Operating expense total | 13.1M | 12.6M | 16.3M |
| EBIT | (463.6K) | (624.6K) | (625.3K) |
| EBIT margin, % | -1.8% | -2.5% | -2.2% |
| Interest expense | 126.3K | 111.6K | 95.7K |
| Pre tax profit | (589.9K) | (736.2K) | (721.0K) |
| Income tax expense | (228.5K) | (236.2K) | (118.2K) |
| Net Income | (361.4K) | (500.0K) | (602.8K) |